Sanofi (SNY) Acquisitions (2023 - 2026)
Sanofi's Acquisitions history spans 4 years, with the latest figure at -$2.0 billion for Q1 2026.
- On a quarterly basis, Acquisitions changed N/A to -$2.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$17.6 billion, a N/A change, with the full-year FY2025 number at -$12.8 billion, down 377.35% from a year prior.
- Acquisitions hit -$2.0 billion in Q1 2026 for Sanofi, up from -$12.8 billion in the prior quarter.
- Over the last five years, Acquisitions for SNY hit a ceiling of -$90.2 million in Q1 2024 and a floor of -$12.8 billion in Q4 2025.
- Historically, Acquisitions has averaged -$4.2 billion across 4 years, with a median of -$2.7 billion in 2024.
- Biggest five-year swings in Acquisitions: rose 20.87% in 2024 and later plummeted 376.97% in 2025.
- Tracing SNY's Acquisitions over 4 years: stood at -$3.4 billion in 2023, then rose by 20.87% to -$2.7 billion in 2024, then plummeted by 376.97% to -$12.8 billion in 2025, then soared by 84.41% to -$2.0 billion in 2026.
- Business Quant data shows Acquisitions for SNY at -$2.0 billion in Q1 2026, -$12.8 billion in Q4 2025, and -$2.7 billion in Q4 2024.